LANLUMA V

LANLUMA® V is a poly-L-lactic acid (PLLA) collagen-stimulating injectable designed for facial rejuvenation and small-area corrections. It works by gradually stimulating the body’s own natural collagen production, resulting in a restored, youthful appearance with volume improvement and skin tightening. Unlike traditional dermal fillers, LANLUMA® V doesn’t just fill space—it promotes dermal regeneration for results that evolve naturally over 2–3 months and last up to two years. It is ideal for use on the face, neck, jawline, and décolletage, helping correct fine lines, deep folds, loss of volume, and other signs of aging.

• Minimally invasive outpatient treatment
• Results last up to 2 years
• Developed by Sinclair Pharma
• Specifically formulated for facial rejuvenation and contouring
  

LANLUMA® V is injected into the dermis or subdermal space using a needle or cannula, following reconstitution with sterile water. Treatment includes a series of sessions spaced weeks apart.

• Reconstitution time: Ready in approximately 10 minutes
• Injection method: Needle or cannula, depending on treatment site
• Recommended sessions: 1–3 treatments spaced over a few months
• Full effect: Visible from 6 weeks onward
• Downtime: Minimal; most patients resume activities same day 

LANLUMA® V is indicated for the correction of facial volume loss, deep lines, and age-related contour changes through stimulation of natural collagen. It is suitable for a wide range of facial rejuvenation needs.

Indications:

• Nasolabial folds, cheeks, chin, jawline, and temples
• Loss of volume and facial sagging
• Skin rejuvenation and texture improvement

Contraindications:

• Use near the lips or periorbital area is contraindicated
• V-shaped buttocks (for body use)
• Active skin infections, autoimmune disease, or hypersensitivity to ingredients

Side Effects:

• Mild swelling, bruising, or tenderness at injection site
• Rare: Nodules, inflammation, or delayed granuloma formation
  

LANLUMA® V contains 210 mg of poly-L-lactic acid (PLLA), a biodegradable, biocompatible polymer from the alpha-hydroxy acid family. It has been safely used in various medical applications for decades.

• Active ingredient: Poly-L-lactic acid (PLLA) – 210 mg
• Form: Lyophilized powder, to be reconstituted
• Type: Class III medical device
• Mechanism: Stimulates fibroblast activity and collagen production

Each package contains one vial of the dry PLLA powder, which must be reconstituted with sterile water before injection.

• 1 x vial of LANLUMA® V (PLLA 210 mg)
• For use in small and precise treatment areas
• Packaged for single use and sterile reconstitution
• Supplied by Sinclair Pharma
  

LANLUMA® V is generally well tolerated, though, as with all injectables, minor and temporary effects can occur. Serious complications are rare when administered correctly.

• Temporary swelling, redness, or bruising
• Mild tenderness at the injection site
• Possible nodules or lumps with improper injection technique
• Massage after treatment helps reduce risk of complications
  

To maintain stability and sterility, LANLUMA® V should be stored under controlled medical storage conditions.

• Storage temperature: Below 25°C (77°F)
• Keep in original packaging until use
• Protect from moisture and light
• Do not freeze
• Once reconstituted, use immediately or according to handling guidelines